Search
gemtuzumab
Recombinant humanized IgG4 kappa with specific binding to the CD33 antigen. Component of Mylotarg off US market.
Interactions
drug adverse effects of pharmaceutical monoclonal antibodies
Related
CD33; myeloid cell surface antigen CD33; sialic acid-binding Ig-like lectin 3; siglec-3; gp67 (SIGLEC3)
General
pharmaceutical monoclonal antibody
recombinant protein; chimer
References
Kaiser Permanente Northern California Regional Drug Formulary,
2000
Component-of
gemtuzumab ozogamicin (Mylotarg)